“Past research on the effects of beta blockers included a majority of participants who were men, so we sought to examine how sex/gender plays a role in the patient outcomes,” according to Raffaele Bugiardini, M.D., professor of cardiology at the University of Bologna and lead author of the study.
“Women are historically underrepresented in most clinical studies on hypertension. It’s important to include an equal split of male and female patients in future research, which could shed light on disparities and actionable treatments.”
